US Stock MarketDetailed Quotes

MGRX Mangoceuticals

Watchlist
  • 2.500
  • +0.030+1.21%
Trading Dec 4 09:31 ET
6.22MMarket Cap-572P/E (TTM)

Mangoceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.85%-1.17M
11.42%-1.58M
45.19%-991.13K
-419.66%-7M
-161.37%-1.7M
-184.96%-1.71M
-2,185.38%-1.78M
-9,570.06%-1.81M
-1.35M
-3,607.53%-649.56K
Net income from continuing operations
-11.13%-2M
-4.70%-2.39M
7.55%-2.37M
-361.07%-9.21M
-281.21%-2.57M
-84.50%-1.8M
-593.21%-2.28M
-12,966.41%-2.56M
---2M
-3,705.75%-673.66K
Operating gains losses
--0
----
----
----
----
----
----
----
---151.82K
----
Depreciation and amortization
-95.99%252
-48.51%3.21K
2.33%6.22K
544.29%24.89K
62.85%6.29K
--6.29K
--6.22K
--6.08K
--3.86K
--3.86K
Other non cash items
300.78%503.21K
113.43%808.4K
-40.65%416.5K
178.88%1.52M
513.31%318.09K
-53.01%125.56K
67.16%378.77K
78,838.13%701.76K
--546.54K
28,554.70%51.87K
Change In working capital
81.83%-19.98K
-634.46%-289.57K
4,789.18%915.8K
120.00%41.51K
108.96%116.84K
-77.25%-109.98K
116.72%54.18K
---19.53K
--18.87K
--55.92K
-Change in receivables
----
----
----
131.55%54.98K
----
----
----
----
---174.24K
----
-Change in inventory
-57.87%806
101.84%433
--4.05K
---18.5K
--3.08K
--1.91K
---23.49K
--0
--0
--0
-Change in prepaid assets
142.06%13.3K
317.60%46.75K
104.62%902
-71.53%-49.21K
159.40%23.43K
16.16%-31.62K
---21.49K
---19.53K
---28.69K
--9.03K
-Change in payables and accrued expense
192.66%36.21K
-436.02%-335.81K
--911.79K
204.92%110.97K
40.26%50.1K
-60.59%-39.07K
299.75%99.94K
--0
--36.39K
--35.72K
-Change in other current assets
----
-45.42%14.78K
--14.47K
----
----
----
--27.08K
--0
----
----
-Change in other current liabilities
-190.68%-41.04K
43.57%-15.72K
---15.41K
-130.60%-56.73K
-107.95%-14.75K
---14.12K
---27.86K
--0
--185.41K
--185.41K
Cash from discontinued investing activities
Operating cash flow
31.85%-1.17M
11.42%-1.58M
45.19%-991.13K
-419.66%-7M
-161.37%-1.7M
-184.96%-1.71M
-2,185.67%-1.78M
-9,564.90%-1.81M
---1.35M
-3,607.53%-649.56K
Investing cash flow
Cash flow from continuing investing activities
0
65K
0
91.84%-3.52K
0
0
0
-3.52K
-43.1K
-40.57K
Net PPE purchase and sale
---65K
--65K
--0
91.84%-3.52K
--0
--0
--0
---3.52K
---43.1K
---40.57K
Cash from discontinued investing activities
Investing cash flow
--0
--65K
--0
91.84%-3.52K
--0
--0
--0
---3.52K
---43.1K
---40.57K
Financing cash flow
Cash flow from continuing financing activities
750K
131.99%1.99M
-94.65%267.5K
244.26%7.06M
140.24%1.2M
0
3,337.79%857.04K
9,900.00%5M
2.05M
1,146.57%499.5K
Net issuance payments of debt
--0
159.72%100K
--87.5K
-435.39%-167.46K
--0
--0
-771.72%-167.46K
--0
--49.93K
--0
Net common stock issuance
--0
--388.27K
-96.40%180K
210.00%6.2M
140.24%1.2M
--0
--0
--5M
--2M
62,337.50%499.5K
Net preferred stock issuance
--750K
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
----
----
--1.02M
--0
--0
----
----
--0
--0
Cash from discontinued financing activities
Financing cash flow
--750K
131.99%1.99M
-94.65%267.5K
244.26%7.06M
140.24%1.2M
--0
3,337.79%857.04K
9,900.00%5M
--2.05M
1,146.57%499.5K
Net cash flow
Beginning cash position
-83.37%490.24K
-99.60%15.31K
8.22%739.01K
2,928.20%682.86K
41.59%1.24M
339,473.16%2.95M
7,089.89%3.87M
2,928.20%682.86K
--22.55K
--873.49K
Current changes in cash
75.69%-415.83K
151.54%476.03K
-122.70%-723.63K
-91.50%56.15K
-161.10%-497.74K
-296.05%-1.71M
-1,643.46%-923.54K
10,089.13%3.19M
--660.31K
-945.37%-190.63K
Effect of exchange rate changes
---497
---1.1K
---70
----
----
--0
--0
--0
----
----
End cash Position
-94.02%73.91K
-83.37%490.24K
-99.60%15.31K
8.22%739.01K
8.22%739.01K
41.59%1.24M
339,473.16%2.95M
7,089.89%3.87M
--682.86K
2,928.20%682.86K
Free cash flow
31.85%-1.17M
11.42%-1.58M
45.30%-991.13K
-403.80%-7M
-146.00%-1.7M
-183.76%-1.71M
-2,185.67%-1.78M
-9,583.70%-1.81M
---1.39M
-3,839.10%-690.13K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.85%-1.17M11.42%-1.58M45.19%-991.13K-419.66%-7M-161.37%-1.7M-184.96%-1.71M-2,185.38%-1.78M-9,570.06%-1.81M-1.35M-3,607.53%-649.56K
Net income from continuing operations -11.13%-2M-4.70%-2.39M7.55%-2.37M-361.07%-9.21M-281.21%-2.57M-84.50%-1.8M-593.21%-2.28M-12,966.41%-2.56M---2M-3,705.75%-673.66K
Operating gains losses --0-------------------------------151.82K----
Depreciation and amortization -95.99%252-48.51%3.21K2.33%6.22K544.29%24.89K62.85%6.29K--6.29K--6.22K--6.08K--3.86K--3.86K
Other non cash items 300.78%503.21K113.43%808.4K-40.65%416.5K178.88%1.52M513.31%318.09K-53.01%125.56K67.16%378.77K78,838.13%701.76K--546.54K28,554.70%51.87K
Change In working capital 81.83%-19.98K-634.46%-289.57K4,789.18%915.8K120.00%41.51K108.96%116.84K-77.25%-109.98K116.72%54.18K---19.53K--18.87K--55.92K
-Change in receivables ------------131.55%54.98K-------------------174.24K----
-Change in inventory -57.87%806101.84%433--4.05K---18.5K--3.08K--1.91K---23.49K--0--0--0
-Change in prepaid assets 142.06%13.3K317.60%46.75K104.62%902-71.53%-49.21K159.40%23.43K16.16%-31.62K---21.49K---19.53K---28.69K--9.03K
-Change in payables and accrued expense 192.66%36.21K-436.02%-335.81K--911.79K204.92%110.97K40.26%50.1K-60.59%-39.07K299.75%99.94K--0--36.39K--35.72K
-Change in other current assets -----45.42%14.78K--14.47K--------------27.08K--0--------
-Change in other current liabilities -190.68%-41.04K43.57%-15.72K---15.41K-130.60%-56.73K-107.95%-14.75K---14.12K---27.86K--0--185.41K--185.41K
Cash from discontinued investing activities
Operating cash flow 31.85%-1.17M11.42%-1.58M45.19%-991.13K-419.66%-7M-161.37%-1.7M-184.96%-1.71M-2,185.67%-1.78M-9,564.90%-1.81M---1.35M-3,607.53%-649.56K
Investing cash flow
Cash flow from continuing investing activities 065K091.84%-3.52K000-3.52K-43.1K-40.57K
Net PPE purchase and sale ---65K--65K--091.84%-3.52K--0--0--0---3.52K---43.1K---40.57K
Cash from discontinued investing activities
Investing cash flow --0--65K--091.84%-3.52K--0--0--0---3.52K---43.1K---40.57K
Financing cash flow
Cash flow from continuing financing activities 750K131.99%1.99M-94.65%267.5K244.26%7.06M140.24%1.2M03,337.79%857.04K9,900.00%5M2.05M1,146.57%499.5K
Net issuance payments of debt --0159.72%100K--87.5K-435.39%-167.46K--0--0-771.72%-167.46K--0--49.93K--0
Net common stock issuance --0--388.27K-96.40%180K210.00%6.2M140.24%1.2M--0--0--5M--2M62,337.50%499.5K
Net preferred stock issuance --750K------------------0----------------
Proceeds from stock option exercised by employees --0----------1.02M--0--0----------0--0
Cash from discontinued financing activities
Financing cash flow --750K131.99%1.99M-94.65%267.5K244.26%7.06M140.24%1.2M--03,337.79%857.04K9,900.00%5M--2.05M1,146.57%499.5K
Net cash flow
Beginning cash position -83.37%490.24K-99.60%15.31K8.22%739.01K2,928.20%682.86K41.59%1.24M339,473.16%2.95M7,089.89%3.87M2,928.20%682.86K--22.55K--873.49K
Current changes in cash 75.69%-415.83K151.54%476.03K-122.70%-723.63K-91.50%56.15K-161.10%-497.74K-296.05%-1.71M-1,643.46%-923.54K10,089.13%3.19M--660.31K-945.37%-190.63K
Effect of exchange rate changes ---497---1.1K---70----------0--0--0--------
End cash Position -94.02%73.91K-83.37%490.24K-99.60%15.31K8.22%739.01K8.22%739.01K41.59%1.24M339,473.16%2.95M7,089.89%3.87M--682.86K2,928.20%682.86K
Free cash flow 31.85%-1.17M11.42%-1.58M45.30%-991.13K-403.80%-7M-146.00%-1.7M-183.76%-1.71M-2,185.67%-1.78M-9,583.70%-1.81M---1.39M-3,839.10%-690.13K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD